Doseology Sciences Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a DOSEF research report →
Price Chart
About the company
Doseology Sciences Inc. is a Canadian firm dedicated to the cultivation and extraction of ingredients for both nutraceutical and pharmaceutical applications. The company's primary focus lies in the research, development, and commercialization of medicinal mushroom products, offered in various forms such as tinctures and powders.
- CEO
- Christopher Jackson
- IPO
- 2022
- Employees
- 3
- HQ
- Kelowna, BC, CA
Get TickerSpark's AI analysis on DOSEF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $501.36K
- P/E
- -0.98
- PEG
- 0.02
- P/S
- 14.30
- P/B
- 1.61
- EV/EBITDA
- -0.67
- Div Yield
- 0.00%
- Gross Margin
- -517.35%
- Op Margin
- -1462.99%
- Net Margin
- -1439.30%
- ROE
- -85.01%
- ROIC
- -107.98%
Latest fiscal year · YoY change
- Revenue
- $31.26K-68.3%
- Gross Profit
- $18.89K-73.8%
- Op Income
- $-346,394
- Net Income
- $-328,900+3.2%
- EPS
- $-0.07+10.7%
- OCF Growth
- -45.6%
- FCF Growth
- -45.6%
- 52W High
- $1.00
- 52W Low
- $0.01
- 50D MA
- $0.11
- 200D MA
- $0.37
- Beta
- 2.25
- RSI (14)
- 29
- Avg Volume
- 210
No earnings-call transcripts are available for DOSEF yet.
- Free Float
- 43.2%
- Shares Outstanding
- 4.50M
- Float Shares
- 1.94M
Our DOSEF coverage
Recent articles, reports, and earnings notes.
No research on DOSEF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate DOSEF report →Doseology Announces $2M Financing to Accelerate Commercialization of Oral Stimulant Pouch Platform
prnewswire.com · Mar 30
Doseology Uplists to OTCQB as DOSEF, Expanding U.S. Investor Access to the Emerging Oral Stimulant Pouch Category
prnewswire.com · Mar 11
Doseology Launches Feed That Brain® Oral Stimulant Pouches in the U.S. Through Direct-to-Consumer Pilot
prnewswire.com · Mar 4
Doseology Appoints Larry Latowsky as Executive Chairman of the Board of Directors
prnewswire.com · Feb 20
Accessible Health Platforms Gain Scale Across $6T Health and Wellness Market
prnewswire.com · Feb 13
Doseology Begins Pilot Production of Caffeine-Based Energy Pouches as Feed That Brain® Enters Oral Stimulant Format
prnewswire.com · Jan 21
2026 Asset Growth: Why Federal Compliance Is the New Metric
globenewswire.com · Jan 19
The Compliance Imperative: Regulatory Moats Driving 2026 Asset Re-Ratings
prnewswire.com · Jan 19
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.